ARTV · Artiva Biotherapeutics Inc
United States · RS rating 15 · As of 2026-11-03
| Price | 4.20 USD |
|---|---|
| 1-day change | +0.2% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 6 / 5 / 51 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 26 / 21 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +33.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +68.6% |
| Market cap (USD) | $279.3M |